Asset Due Diligence and Technology Selection

Seohae Holdings applies a differentiated due diligence method and operates its own
proprietary system for discovering high-potential technologies.

By conducting asset due diligence on numerous bio/pharmaceutical intellectual properties developed
by domestic universities, government-funded research institutes, and early-stage biotech ventures,
we identify outstanding technologies that align with global demand. We provide support to ensure
that these selected technologies are successfully transferred or commercialized in the global market.

Main Services

Data Investigation

Conduct due diligence and evaluation of intellectual property held
by universities, research institutes, and companies.
Establish criteria for identifying promising technologies with
strong commercialization potential and review candidate technologies.
Examples include : patent filing date, request for examination, review of claims and embodiments, family patents, registration status, citation analysis, and more. Examine methodologies for discovering technologies suitable for marketing.
Categorize candidate technologies as platform technologies or novel drug candidates and develop tailored marketing strategies for each.
Identify the inventors behind marketable technologies.
Conduct a brief analysis of global market trends and competitiveness for each technology.

Inventor Interviews

Arrange meetings and lab visits with inventors to discuss the technologies identified for marketing.
Conduct interviews to understand the background of the invention, its implementation status, available funding, future research plans, and current or planned government grant applications.
Evaluate the inventor’s research capabilities and team structure.
Review the materials provided for the invention and discuss any necessary supplements
Provide consulting on the key elements required to promote the invention in global markets.
Review the preparation of SMKs, teasers, and pitch decks, and assist in document development.